Novo Nordisk is rebranding as 'Novo' to fight Eli Lilly for obesity market share
- Novo Nordisk: 4 events in the last 90 days
- Previous: earlier the same day · Novo Nordisk rebrands as Novo to compete in obesity market
What happened
The Danish drugmaker unveiled a new name, slogan, and set of cultural principles as it trails Eli Lilly in the obesity drug market
Summary assembled by rule from the sources below